Shoppers Drug Mart Corp (SC.TO) Buy, Sell or…

Shoppers Drug Mart Corp (SC.TO)

0.00

-0.00 (0.00%)

56 watching

DON'T BUY

(Market Call Minute) In a transition. Battles last year with Ontario government. Difficult to see how they can grow the business like in the last 5 years.

Wealthica Track your Stocks in your Watch List

DON'T BUY

Even though Target will create competition, he does not think it is a takeover target. They will be hurt by more US competition. Decent dividend but being assaulted on all sides by competition and government regulations.

WEAK BUY

Is a stable stock, stays near $50. No news, but is up. Expects a pullback but if stock can break above $49. If it can make another dollar or two it might be worth an investment.

PAST TOP PICK

(Top Pick Feb 23/11, Up 6.96%)

BUY

(Market Call Minute.) Raising dividends and cash flow is tremendous. Hated by the street, but buy for the long-term.

DON'T BUY

Ontario legislation on generic drugs was a real blow to the company. Would take a look at this if it got back into the low $30's range.

BUY

Ended year well, one of the better performing stocks on the TSX. Pulled back on news of target’s announcement of expanding into Canada with pharmacies in their stores. Looking at 13-14% earnings growth. Take advantage of dip.

DON'T BUY

There is too much competition. Everyone is getting into everyone else's business. Thinks there is going to be continuing pressure on all avenues of retail.

Wealthica Track your Stocks in your Watch List

PAST TOP PICK

(A Top Pick Sept 22/11. Up 3.11%.)

HOLD

There is more colour coming on this in the month of November. Good margins in the from store and they are having some growth. Not inexpensive. He would focus on discount retail.

TOP PICK

[Program signal failed in Sept. Also the web site did not record a clip for top picks. No opinions were recorded for Top Picks. This item was inserted on Nov 30/11.]

DON'T BUY

Safe in this type of environment because of study earnings, but finds the valuations somewhat rich at a 13 multiple. Growth is slow down a little because of drug legislation.

DON'T BUY

The problem here is more political than it is pricing. He sold his holdings some time ago until he could get a clearer picture of where the government regulations where to go on the pricing of drugs. Also yield is not high enough to attract him.

BUY

Hasn't like this one for 4 or 5 years. Got cheaper with the Ontario rule changes and is looking better. Front store sales are really doing well. And be surprised to see it in the mid-$40's in the next 8-12 months.

DON'T BUY

Loblaws (L-T) or Shoppers (SC-T)? Doesn't particularly like either of them. If he had to pick one he would give the benefit of the doubt to Shoppers.

Showing 46 to 60 of 452 entries

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Shoppers Drug Mart Corp (SC.TO)